These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [New results in the clinical investigation of the fat metabolism]. Schettler G Folia Clin Int (Barc); 1976 Oct; 26(10):391-411. PubMed ID: 187457 [No Abstract] [Full Text] [Related]
4. Lipolytic enzymes and plasma lipoprotein metabolism. Nilsson-Ehle P; Garfinkel AS; Schotz MC Annu Rev Biochem; 1980; 49():667-93. PubMed ID: 6996570 [No Abstract] [Full Text] [Related]
5. Current status of the nosology of the hyperlipidemias. Bilheimer DW Birth Defects Orig Artic Ser; 1978; 14(6B):47-67. PubMed ID: 215244 [No Abstract] [Full Text] [Related]
6. [Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III]. Augustin J; Geursen R; Wieland H; Klose G; Greten H Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():387-9. PubMed ID: 206056 [No Abstract] [Full Text] [Related]
7. [Neonatal hyperlipemia due to lipoprotein lipase deficiency]. Thouvenot JP; Ghisolfi G; Douste-Blazy L Ann Biol Clin (Paris); 1973; 31(2):127-8. PubMed ID: 4356110 [No Abstract] [Full Text] [Related]
9. The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism. Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Brady DW; Gartside P; Glueck CJ Lipids; 1978 Dec; 13(12):933-42. PubMed ID: 220489 [No Abstract] [Full Text] [Related]
10. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Zilversmit DB Circ Res; 1973 Dec; 33(6):633-8. PubMed ID: 4361710 [No Abstract] [Full Text] [Related]
12. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]
14. [Lipoproteins lipase and its effect on very low density lipoproteins]. Polonovski J; Glangeaud-Freudenthal MC Expos Annu Biochim Med; 1982; 35():13-37. PubMed ID: 7037450 [No Abstract] [Full Text] [Related]
15. [Pathogenesis of hyperlipoproteinemias]. Müller G Z Gesamte Inn Med; 1974 Jun; 29(12):469-76. PubMed ID: 4368206 [No Abstract] [Full Text] [Related]
16. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors. Sehayek E; Eisenberg S Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482 [No Abstract] [Full Text] [Related]
17. [Lipid tolerance and lipoprotein lipases in normal persons and hypertriglyceridemia patients]. Hansen W Verh Dtsch Ges Inn Med; 1973; 79():1276-8. PubMed ID: 4790156 [No Abstract] [Full Text] [Related]
18. [Lipid metabolism disorders in patients with chronic renal failure]. Zdrojewski Z Pol Tyg Lek; 1982 May; 37(13):391-3. PubMed ID: 7134045 [No Abstract] [Full Text] [Related]
19. The preheparin and postheparin lipids of high density lipoprotein subfractions: relation to the serum insulin and postheparin plasma lipase activities in normal human. Skottová N; Vaverková H; Vecera R; Bartek J Acta Univ Palacki Olomuc Fac Med; 1992; 134():69-74. PubMed ID: 1364970 [TBL] [Abstract][Full Text] [Related]
20. [Lipoprotein lipase. Physiology and pathophysiology]. Persson B Nord Med; 1971 Mar; 85(9):261-6. PubMed ID: 4929031 [No Abstract] [Full Text] [Related] [Next] [New Search]